AbbVie shares hit record high as key immunology drug set for exclusivity until 2037
By Christy Santhosh (Reuters) -AbbVie shares rose 4% to a record high on Thursday after...
By Christy Santhosh (Reuters) -AbbVie shares rose 4% to a record high on Thursday after...
By Jonathan Stempel (Reuters) -A federal appeals court on Thursday rejected Eli Lilly’s appeal of...
(Reuters) -Delta Air Lines on Thursday reaffirmed its full-year and current-quarter earnings forecasts, betting on...
Scary New Prediction: Your Money Seized?! 💰 $20 = Ounce of Gold? Scary New Prediction:...
(Reuters) -Nvidia said on Tuesday it would launch a new artificial intelligence chip by the...
(Clarifies timing of Goldman Sachs note which went to clients on September 2, not this...
By Jeff Mason and Steve Holland WASHINGTON (Reuters) – U.S. President Donald Trump feels “very...
By Tatiana Bautzer NEW YORK (Reuters) – Citigroup Chief Financial Officer Mark Mason said at...
By Nupur Anand NEW YORK (Reuters) -JPMorgan Chase Co-CEO of investment banking Doug Petno said...
(Reuters) – Intel announced a series of high-level executive changes on Monday, including the departure...